CARE
Carter Bankshares, Inc. · Financials · Banks - Regional
Last
$20.84
−$0.70 (−3.23%) 4:00 PM ET
After hours $20.84 +$0.00 (+0.02%) 7:12 PM ET
Prev close $21.53
Open $21.31
Day high $21.48
Day low $20.74
Volume 203,416
Avg vol 163,527
Mkt cap
$460.21M
P/E ratio
15.32
FY Revenue
$251.97M
EPS
1.36
Gross Margin
58.70%
Sector
Financials
AI report sections
CARE
Carter Bankshares, Inc.
Carter Bankshares shows firm upward price momentum over 1–12 months with the stock now near its 52-week high, supported by multiple bullish technical signals. Fundamentally, the bank delivers solid profitability and free cash flow with modest revenue growth but faces flat earnings progression and only moderate returns on equity. Valuation appears moderate on earnings and free cash flow metrics while short interest and days-to-cover are elevated enough to signal some ongoing skepticism and risk.
AI summarized at 1:28 AM ET, 2026-02-03
AI summary scores
INTRADAY: 63 SWING: 74 LONG: 69
Volume vs average
Intraday (cumulative)
+29% (Above avg)
Vol/Avg: 1.29×
RSI
54.52 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.02 Signal: -0.02
Short-Term
-0.12 (Weak)
MACD: 0.23 Signal: 0.35
Long-Term
-0.08 (Weak)
MACD: 0.64 Signal: 0.72
Intraday trend score 40.12

Latest news

CARE 12 articles Positive: 1 Neutral: 2 Negative: 0
Neutral Benzinga • Prnewswire
First Reliance Bancshares Reports Third Quarter 2025 Results

First Reliance Bancshares reported strong Q3 2025 financial performance, with net income increasing 48.8% to $2.7 million, improved net interest margin, and growing tangible book value per share by 14.6%.

FSRL CARE banking financial results earnings net income net interest margin
Sentiment note

Mentioned as a bank that purchased two North Carolina branch locations from First Reliance Bancshares in Q2 2025

Neutral The Motley Fool • Jesterai
Carter Bankshares EPS Jumps 76% in Q2

Carter Bankshares reported Q2 2025 earnings with a strong EPS of $0.37, beating expectations, while experiencing revenue challenges and ongoing exposure to nonperforming loans from Justice Entities.

CARE FSRL earnings regional banking commercial lending net interest margin nonperforming loans
Sentiment note

Mixed financial performance with positive EPS and improved asset quality, but challenges in revenue, deposit growth, and ongoing nonperforming loan exposure

Positive GlobeNewswire Inc. • C.D. Carter
THOUGHTS OF STERLING Explores Love’s Dark Complexity Through Poetry

A new poetry collection, 'Thoughts of Sterling' by author C.D. Carter, delves into the dark emotions and experiences surrounding love, heartbreak, and romantic loss. The collection uses vivid language and symbolism to explore the contrasts of the human spirit, encouraging readers to reflect on their own journeys and the shared experience of love and pain.

CARE poetry love heartbreak romantic loss
Sentiment note

C.D. Carter is the author of the poetry collection, 'Thoughts of Sterling,' which is described as a remarkable and essential read that will resonate with readers.

Unknown Zacks Investment Research • Santanu Roy
Take the Zacks Approach to Beat the Markets: NVIDIA, Seagate, Amkor in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

GS UNH NVO AMGN
Unknown Zacks Investment Research • Zacks Equity Research
Carter Bankshares (CARE) Soars 5.2%: Is Further Upside Left in the Stock?

Carter Bankshares (CARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

CARE MSBI
Unknown Zacks Investment Research • Zacks Equity Research
Surging Earnings Estimates Signal Upside for Carter Bankshares (CARE) Stock

Carter Bankshares (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CARE
Unknown Zacks Investment Research • Zacks Equity Research
How Much Upside is Left in Carter Bankshares (CARE)? Wall Street Analysts Think 28.92%

The mean of analysts' price targets for Carter Bankshares (CARE) points to a 28.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CARE
Unknown Zacks Investment Research • Zacks Equity Research
Implied Volatility Surging for Carter Bankshares (CARE) Stock Options

Investors need to pay close attention to Carter Bankshares (CARE) stock based on the movements in the options market lately.

CARE
Unknown Zacks Investment Research • Zacks Equity Research
Wall Street Analysts See a 30.85% Upside in Carter Bankshares (CARE): Can the Stock Really Move This High?

The consensus price target hints at a 30.9% upside potential for Carter Bankshares (CARE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

CARE
Unknown Zacks Investment Research • Zacks Equity Research
Compared to Estimates, Carter Bankshares (CARE) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

CARE
Unknown Zacks Investment Research • Zacks Equity Research
Cambridge (CATC) Q1 Earnings and Revenues Lag Estimates

Cambridge (CATC) delivered earnings and revenue surprises of -2.86% and 1.42%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

CATC CARE
Unknown Zacks Investment Research • Zacks Equity Research
Carter Bankshares, Inc. (CARE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Carter Bankshares, Inc. (CARE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

CARE
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal